Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 10Completed 4Not yet recruiting 3Active not recruiting 3Terminated 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasms 2Cancer Patients 1

Interventions

pembrolizumab 374Carboplatin 276Specimen Handling 265Nivolumab 252Magnetic Resonance Spectroscopy 244Cyclophosphamide 240Cisplatin 213Paclitaxel 206Radiotherapy 195Biopsy 171Gemcitabine 155Dexamethasone 148durvalumab 143atezolizumab 126Rituximab 120Doxorubicin 115Bevacizumab 114Lenalidomide 113Ipilimumab 111Radiation 109Docetaxel 103Pemetrexed 102Etoposide 101fludarabine 97venetoclax 95Fluorouracil 92Capecitabine 92Radiosurgery 90Prednisone 89Oxaliplatin 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Focus Groups × 1 year × Clear all
NCT01603316 2026-03-12

Food: A Three-Arm Study Examining Food Insecurity Interventions

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
606 enrolled

Cancer Patients

NCT06549153 2026-03-09

ACT-Together (Acting on Cancer Testing-Together)

M.D. Anderson Cancer Center

Phase NA Active not recruiting
30 enrolled
Tumor-Agnostic

Neoplasms

NCT00832325 2026-03-03

Adolescent and Young Adult Cancer Survivors: Identity Development

Memorial Sloan Kettering Cancer Center

Active not recruiting
300 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡